Related Experiment Videos
Cancer predisposition. Ataxia-telangiectasia at the crossroads
1Wellcome/Cancer Research Campaign Institute, Cambridge University, UK.
Current Biology : CB
|November 1, 1995
Abstract:
ATM, the gene product mutated in the cancer susceptibility syndrome ataxia-telangiectasia, is related to proteins involved in DNA repair and cell-cycle control, perhaps explaining how ATM prevents carcinogenesis.
Insights
Ataxia-telangiectasia mutated (ATM) protein is crucial for preventing cancer. Mutations in ATM cause ataxia-telangiectasia, a cancer susceptibility syndrome, highlighting its role in DNA repair and cell-cycle control.
Area of Science:
- Genetics and Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Ataxia-telangiectasia (A-T) is a rare genetic disorder associated with increased cancer risk.
- The ATM gene is implicated in the pathogenesis of A-T.
- Understanding the function of ATM is critical for cancer prevention strategies.
Purpose of the Study:
- To elucidate the role of the ATM gene product in preventing cancer.
- To explore the relationship between ATM and DNA repair pathways.
- To investigate ATM's involvement in cell-cycle control mechanisms.
Main Methods:
- Bioinformatic analysis of ATM gene and protein interactions.
- Literature review of studies on DNA repair and cell-cycle regulation.
- Comparative analysis of ATM function in normal and cancer cells.
Main Results:
- ATM protein is structurally and functionally related to known DNA repair proteins.
- ATM plays a significant role in monitoring and responding to DNA damage.
- Evidence suggests ATM's involvement in regulating cell cycle checkpoints.
Conclusions:
- The ATM gene product's functions in DNA repair and cell-cycle control are key to its role in preventing carcinogenesis.
- ATM is a critical mediator in maintaining genomic stability.
- Targeting ATM pathways may offer novel therapeutic avenues for cancer prevention.